HCG on Cycle and in PCT: Dosage, Timing, Common Mistakes

HCG on Cycle and in PCT: Dosage, Timing, Common Mistakes

TL;DR

• HCG (human chorionic gonadotropin) mimics LH and keeps the testes active during a suppressive cycle, making post-cycle recovery faster and less painful.
• The standard on-cycle dose is 250–500 IU two to three times per week; more is not better and increases oestradiol and desensitisation risk.
• HCG is used during the cycle or in the gap between the last injection and PCT — never in parallel with the SERM phase, because it is itself suppressive to the HPTA axis.
• Stop HCG roughly 3–7 days before starting the SERM; PCT then runs about four weeks with tamoxifen 20–40 mg/day and/or clomiphene 25–50 mg/day.
• PCT is a male protocol — women do not need it, as they have no hypothalamic-pituitary-testicular axis to restart.
• Common mistakes: running HCG throughout PCT, megadosing once at the end of the cycle, ignoring the oestradiol it raises, and skipping the bloodwork that tells you whether recovery actually happened.

What HCG Is and Why It Is Used

Human chorionic gonadotropin is a hormone produced in pregnancy, and its clinical uses — from fertility treatment to cryptorchidism — all rest on one property: its molecular structure closely resembles luteinising hormone (LH). In the male body, LH is the signal the pituitary sends to the Leydig cells in the testes to produce testosterone. When you inject exogenous anabolic steroids, the hypothalamic-pituitary-testicular axis (HPTA) shuts down: LH and FSH fall toward zero, the testes stop receiving the signal, and they gradually shrink and lose function. That shutdown is guaranteed on any suppressive cycle, not a matter of bad luck.

HCG steps into that gap as an artificial LH substitute. It stimulates the Leydig cells directly, keeping intratesticular testosterone production alive and preventing the deep testicular atrophy that makes post-cycle recovery slow and miserable. This matters for two reasons. First, recovery: a testis that has been idle for 12–16 weeks responds sluggishly when natural LH returns, extending the hypogonadal crash after the cycle ends. Second, fertility: spermatogenesis depends on high intratesticular testosterone, which exogenous steroids cannot provide but HCG stimulation partially preserves.

What HCG does not do is restart your own axis — and this is the single most misunderstood point. HCG suppresses the hypothalamus and pituitary through the same negative feedback loop as any androgen. It keeps the bottom rung of the axis (the testes) working while the top rungs (hypothalamus and pituitary) stay off. Restarting those top rungs is the job of SERMs in PCT, which is why HCG and SERMs are sequenced, not combined. HCG is available in various preparations in the HCG category, typically as lyophilised powder in ampoules or vials that must be reconstituted with bacteriostatic water and refrigerated.

Dosage: What the Practice Looks Like

HCG dosing norms fall into two distinct patterns depending on when it is used, and confusing them is behind most dosing errors:

The on-cycle approach — 250–500 IU twice or three times weekly, for example 250 IU on Monday, Wednesday, and Friday — is the better-supported strategy. Low, frequent doses maintain testicular function continuously, produce smaller oestradiol spikes, and avoid the Leydig cell desensitisation that large boluses can cause. Some users start HCG only in the final third of the cycle; that is a reasonable compromise on shorter cycles, but on anything beyond 10–12 weeks, earlier and continuous use preserves more function.

The pre-PCT blast is the alternative: skip HCG during the cycle, then run 500–1,000 IU every other day for roughly two weeks in the clearance window after the last injection, stopping before the SERM begins. This re-sensitises and reactivates the testes in one concentrated block. It works, and some prefer it for simplicity, but the higher doses push oestradiol harder and the evidence favours continuous low-dose maintenance for long or heavy cycles.

Two things are not a strategy. Megadoses of 3,000–5,000 IU in single shots — a relic of old forum protocols — spike oestradiol violently and risk desensitising the very receptors you are trying to stimulate. And dribbling HCG through the entire PCT "for safety" actively prevents the recovery PCT exists to create, because the hypothalamus reads HCG-driven testosterone as a reason to stay shut down.

Timing: On Cycle vs. Before PCT

Timing is where HCG protocols succeed or fail, and it hinges on one principle: HCG must be finished before the SERM phase starts. The SERM — tamoxifen at 20–40 mg/day or clomiphene at 25–50 mg/day for about four weeks — works by blocking estrogen receptors at the hypothalamus and pituitary, which lifts the feedback brake and lets LH and FSH rise again. If HCG is still circulating during that phase, its testosterone output feeds the same receptors the SERM is trying to unblock, and the two compounds work against each other.

The practical sequence for a long-ester cycle (testosterone enanthate, cypionate, nandrolone decanoate — the long esters) looks like this:

The clearance window is ester-dependent, exactly as it is for the SERM start itself. Long esters take 14–21 days to clear to non-suppressive levels; HCG can run through the first part of that window because exogenous steroid is still suppressing the axis anyway, but it must stop before the SERM begins. For short esters and oral compounds — where PCT starts only 3–5 days after the last dose — the window for a pre-PCT blast shrinks drastically, which is one reason continuous on-cycle HCG is the cleaner option when orals are involved. The kinetics behind those compressed windows, and why oral half-lives change the whole PCT calendar, are covered in Oral Steroids Half Lives Timing Windows Liver Protection.

One clarification that prevents a persistent misunderstanding: SERMs are selective estrogen receptor modulators. They act on estrogen receptors at the hypothalamus and pituitary — full stop. They are not serotonin antagonists, they have nothing to do with DHT, and they do not "clean" receptors anywhere else. And the entire PCT framework applies to men: women do not experience HPTA suppression in any relevant sense and do not run PCT.

Side Effects and Risks

HCG's side-effect profile follows directly from its mechanism — it raises testosterone inside the testes, and a share of that testosterone aromatises:

• Oestradiol elevation: the dominant issue. Intratesticular aromatisation can push E2 up sharply, especially with blast doses, producing water retention, blood pressure rise, nipple sensitivity, and gynecomastia risk. If bloodwork shows E2 climbing during an HCG phase, the answer is a lower HCG dose first; where an aromatase inhibitor is genuinely warranted, low-dose options such as Anastrazole 1mg/tab 30 Tablets by Magnus Pharmaceuticals or Anastrozol 1mg/tab 28 Tablets by Sandoz are the compounds typically used for that purpose — dosed to bloodwork, never prophylactically, because crashing E2 trades one problem for a worse one.
• Leydig cell desensitisation: sustained high doses can blunt the testes' response to LH/HCG over time — the exact opposite of the goal. This is the mechanistic argument against megadosing.
• Gynecomastia: not theoretical. HCG-driven aromatisation in the final weeks of a cycle, layered on top of residual exogenous steroid, is a classic gyno trigger. Early signs (nipple itching, sensitivity, palpable tissue) demand immediate action.
• Injection-site and general effects: mild injection-site irritation, occasional headache, acne flare, or mood changes from the hormonal shift.
• False recovery signals: HCG keeps testicular volume and libido partially intact, which can mask how suppressed the axis actually is. Feeling fine on HCG is not evidence of recovery — only bloodwork after everything has cleared can show that.

HCG does not cause the classic steroid side effects (lipid damage, haematocrit elevation, hair loss) at typical doses, but it also does not protect against them — it addresses testicular function, nothing else.

Bloodwork and Monitoring

HCG without bloodwork is guesswork with a syringe. The monitoring framework is simple and non-negotiable:

• Baseline (before the cycle): total and free testosterone, LH, FSH, oestradiol (sensitive assay), plus the standard safety panel of lipids, liver enzymes, and haematocrit. You cannot measure recovery against a baseline you never took.
• Mid-cycle: confirms the cycle compounds are real and lets you see whether HCG is pushing E2 beyond what the cycle alone would produce. If E2 is climbing out of range, adjust the HCG dose or frequency before reaching for an AI.
• Four to six weeks after PCT ends: the decisive draw — total and free testosterone, LH, FSH, oestradiol. This is the only way to verify the axis has actually restarted. Drawing blood during or immediately after the SERM phase is misleading, because SERMs artificially elevate LH and FSH while you are taking them.

Marker-by-marker reference ranges and the reasoning behind each test are laid out in Blood Tests On A Steroid Cycle 12 KEY Markers Reference Values. The rule that matters most here: recovery is verified by numbers, not by how you feel, because HCG and SERMs both make you feel recovered before you are.

Common Mistakes

The errors below account for nearly every failed HCG protocol:

1. Running HCG in parallel with the SERM. The most damaging mistake. HCG maintains testicular output that suppresses the hypothalamus, while the SERM tries to unblock it — the protocol cancels itself. Sequence, never stack: HCG first, stop, then SERM.
2. Megadosing at the end of the cycle. A single 5,000 IU shot after twelve weeks of nothing spikes oestradiol, risks receptor desensitisation, and delivers no advantage over a disciplined 500 IU every other day in the clearance window.
3. Treating HCG as PCT. HCG maintains the testes; it does not restart the axis. Men who run HCG for two weeks, feel their libido return, and skip the SERM phase have done half the job and usually pay for it with a prolonged crash weeks later.
4. Ignoring the oestradiol. HCG is itself an aromatisation source. Adding it to a cycle without re-checking E2 is how "I was careful with my AI" turns into gyno in week twelve.
5. Starting HCG too late to matter. Beginning in the final week of a 16-week cycle leaves three months of atrophy unaddressed. If the cycle is long, start HCG early or accept slower recovery.
6. Poor handling. Reconstituted HCG degrades at room temperature within days. It belongs refrigerated, mixed gently (never shaken), and used within its shelf life — otherwise you are injecting progressively weaker solution while believing the dose is constant.

FAQ

Can I use HCG as my entire PCT instead of SERMs?

No. HCG mimics LH at the testicular level but suppresses the hypothalamus and pituitary through negative feedback — the very structures PCT exists to restart. A SERM (tamoxifen 20–40 mg/day or clomiphene 25–50 mg/day for about four weeks) blocks estrogen receptors at the pituitary so LH and FSH rise again. HCG can prepare the testes before that phase; it cannot replace it.

When exactly should I stop HCG before starting the SERM?

Stop HCG roughly 3–7 days before the SERM begins, so exogenous HCG activity has faded when the SERM starts working on the pituitary. On a long-ester cycle, that typically means the last HCG dose around days 10–14 after the final injection, with PCT starting around days 14–21. Overlapping them defeats the purpose of both compounds.

Does HCG on cycle raise my estrogen?

Yes, and meaningfully at higher doses. HCG-driven intratesticular testosterone aromatises, adding to whatever oestradiol your cycle compounds already produce. This is dose-dependent: 250–500 IU twice weekly rarely causes problems, while 1,000+ IU blasts frequently do. Confirm with a mid-cycle sensitive E2 assay rather than guessing from symptoms.

Is the pre-PCT HCG blast better than using it throughout the cycle?

For long or heavy cycles, continuous low-dose use (250–500 IU two to three times weekly) preserves more testicular function and produces smoother hormone levels. The blast approach — 500–1,000 IU every other day for about two weeks before PCT — is a workable alternative for shorter cycles or when on-cycle use was skipped, but it carries more oestradiol risk.

Do women need HCG or PCT after a cycle?

No. PCT exists to restart the male hypothalamic-pituitary-testicular axis, which women do not have. Women do not run SERMs or HCG post-cycle; their considerations after discontinuing a compound are entirely different. HCG protocols discussed here apply exclusively to men recovering from suppressive anabolic use.

How do I know if my recovery actually worked?

Only through bloodwork drawn four to six weeks after the PCT protocol ends: total and free testosterone, LH, and FSH back within or near your baseline range. Testing during the SERM phase is useless because SERMs artificially elevate LH and FSH while active. Feeling recovered is encouraging but proves nothing — HCG and SERMs both mask symptoms.

Conclusion

HCG is a genuinely useful tool with a narrow correct application: low, frequent doses during the cycle (250–500 IU two to three times weekly), or a measured every-other-day block in the clearance window — always finished before the SERM phase begins, never running alongside it. Used that way, it preserves testicular function, shortens the post-cycle crash, and makes the tamoxifen or clomiphene phase work the way it should. Used carelessly — megadosed, overlapped with SERMs, or substituted for them — it does active harm: oestradiol spikes, gynecomastia risk, desensitised Leydig cells, and a recovery that looks fine on the surface while the axis stays shut down underneath. You should not be anywhere near this protocol if you are not running a suppressive cycle, if you cannot commit to baseline and post-PCT bloodwork, or if your plan is to skip the SERM phase because HCG made you feel recovered. Recovery is a laboratory result, not a feeling. Keep the doses low, keep the sequence clean, verify with blood draws before and four to six weeks after — and if any of that discipline is beyond what you can commit to, the honest decision is not to start the cycle in the first place.